Nektar Therapeutics NKTR
NASDAQ NKTR
$59.29 -1.11 (-1.84%)
As of: Sep 29, 2026 · 3:59 PM EDT

Nektar Therapeutics (NKTR) Net Margin (2010 - 2026)

Updated

Nektar Therapeutics' Net Margin was -400.97% in Q2 2026, down 28.77 percentage points from -372.20% a year earlier but up 12.48 percentage points from the prior quarter.

Analysis

Nektar Therapeutics (NKTR) Net Margin (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Nektar Therapeutics' Net Margin was -287.84% through Jun 30, 2026, down 124.66 percentage points year-over-year; for FY2025, it came in at -297.07%, down 176.20 percentage points from FY2024.

  • Net Margin shows a five-year change of -6.42 percentage points (FY2020 to FY2025).
  • In earlier years, Net Margin was -120.86% in FY2024 (+185.45 pp), -306.31% in FY2023 (+93.66 pp), -399.98% in FY2022 (+114.06 pp) and -514.03% in FY2021 (-223.39 pp).
  • Quarterly Net Margin has moved between -736.94% (Q2 2022) and 24.89% (Q4 2024) over five years.
  • Compared with a year earlier, Net Margin was higher in three of the last eight quarters, with an average year-over-year change of -65.27 percentage points.
  • The best year-over-year quarter for Net Margin over five years was Q2 2023 (a gain of 487.55 percentage points); the worst was Q1 2025 (a drop of 316.37 percentage points).
  • Per Business Quant data, NKTR's Net Margin in the three quarters before Q2 2026 was -413.44% (Q1 2026), -165.45% (Q4 2025) and -301.29% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 21.86%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 21.27%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -8.04%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 22.61%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.81%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 23.62%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 32.99%
10 Nektar Therapeutics 2.00 Bn 227.61 Mn - -400.97%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -400.97%
Mar 31, 2026 -413.44%
Dec 31, 2025 -165.45%
Sep 30, 2025 -301.29%
Jun 30, 2025 -372.20%
Mar 31, 2025 -486.44%
Dec 31, 2024 24.89%
Sep 30, 2024 -153.61%
Jun 30, 2024 -222.93%
Mar 31, 2024 -170.07%
Dec 31, 2023 -176.17%
Sep 30, 2023 -189.85%
Jun 30, 2023 -249.39%
Mar 31, 2023 -634.52%
Dec 31, 2022 -271.03%
Sep 30, 2022 -249.94%
Jun 30, 2022 -736.94%
Mar 31, 2022 -364.16%
Dec 31, 2021 -582.37%
Sep 30, 2021 -520.47%
API Access

Nektar Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=NKTR&period=max&api_key=YOUR_API_KEY